|
|
40
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
19.14
|
3.83
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
101.04
|
10.104
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2024-07-19
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
86.64
|
8.664
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-20
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
40
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
26.10
|
5.22
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
41
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP) (BQ)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
29.58
|
5.9151
|
AMP
|
0
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
40
|
07027
|
MESTINON 60MG TAB (VCL/COL) PYRIDOSTIGMINE
|
PYRIDOSTIGMINE
|
MESTINON
|
100'S
|
C
|
217.47
|
2.17
|
TABLET
|
0
|
TAB
|
VCL
|
VALEANT CANADA LTD
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
41
|
07027
|
MESTINON 60MG TAB (VCL) PYRIDOSTIGMINE (C)
|
PYRIDOSTIGMINE
|
MESTINON
|
100'S
|
C
|
217.47
|
2.1747
|
TAB
|
180
|
BOX
|
VCL
|
VALEANT CANADA LTD
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
40
|
0702C
|
PYRIDOSTIGMINE 60MG TAB (SLS/AHI)
|
PYRIDOSTIGMINE
|
PYRIDOSTIGMINE
|
50'S
|
A
|
31.10
|
0.62
|
TABLET
|
180
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
41
|
0702F
|
PYRIDOSTIGMINE 60MG TAB (FSB)
|
PYRIDOSTIGMINE
|
PYRIDOSTIGMINE
|
30'S
|
A
|
8.21
|
0.2736
|
TAB
|
180
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
40
|
0711AF
|
ATROPINE SULPHATE 0.5MG/ML IV/IM INJ (MON/PHA)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10X1ML
|
B
|
6.36
|
0.64
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
AUTONOMIC DRUGS
|
|
|
|
41
|
0711AF
|
ATROPINE SULPHATE 0.5MG/ML IV/IM INJ (MON) (B)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10X1ML
|
B
|
8.32
|
0.8318
|
AMP
|
10
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
41
|
07123
|
ATROPINE MINIMS 1% EYE DR (CAM) ATROPINE SULPHATE (B)
|
ATROPINE SULPHATE
|
ATROPINE MINIMS
|
20X0.5ML
|
B
|
113.49
|
5.6745
|
AMPP
|
20
|
BOX
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5224
|
EENT MYDRIATICS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT MYDRIATICS
|
|
|
|
40
|
07127
|
ATROPINE MINIMS 1% EYE DR (CAM/STO) ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
ATROPINE MINIMS
|
20X0.5ML
|
B
|
94.73
|
4.74
|
EYE DROP
|
0
|
AMP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
5224
|
EENT MYDRIATICS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
40
|
07141
|
ATROPINE SULPHATE 1% EYE DR (ASL/PHA)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10ML
|
A
|
11.66
|
11.66
|
EYE DROP
|
1
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5224
|
EENT MYDRIATICS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
41
|
07141
|
ATROPINE SULPHATE 1% EYE DR (ASL)
|
ATROPINE SULPHATE
|
ATROPINE SULPHATE
|
10ML
|
A
|
13.29
|
13.2926
|
BOTT
|
20
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5224
|
EENT MYDRIATICS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT MYDRIATICS
|
|
|
|
40
|
07211
|
CALCORT 6MG TAB (SFA/COL) DEFLAZACORT
|
DEFLAZACORT
|
CALCORT
|
10'S
|
C
|
27.18
|
2.72
|
TABLET
|
0
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
40
|
07219
|
FLACORT 6MG TAB (ARP/AHI) DEFLAZACORT
|
DEFLAZACORT
|
FLACORT
|
3X10
|
C
|
8.97
|
0.30
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
41
|
0721B
|
DEFLARIN 6MG TAB (EXE) DEFLAZACORT (C)
|
DEFLAZACORT
|
DEFLARIN
|
10'S
|
C
|
2.94
|
0.2936
|
TAB
|
0
|
BOX
|
EXE
|
EXELTIS ILAC
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ADRENALS
|
|
|
|
40
|
07221
|
CALCORT 30MG TAB (SFA/COL) DEFLAZACORT
|
DEFLAZACORT
|
CALCORT
|
10'S
|
C
|
38.06
|
3.81
|
TABLET
|
0
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
40
|
07229
|
AVEXA 30MG TAB (MBL/AHI) DEFLAZACORT
|
DEFLAZACORT
|
AVEXA
|
1X10
|
C
|
29.00
|
2.90
|
TABLET
|
0
|
TAB
|
MBL
|
MEDICAMEN BIOTECH LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat C
|
oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-03-10
|